Jisha Rajendran Keay SD et al. BJOG. 1997.

Slides:



Advertisements
Similar presentations
How Old is Too Old? Age, Genetics and Reproduction
Advertisements

ALTERNATE DAY TRIPTORELIN: A COST EFFECTIVE METHOD FOR CONTROLLED OVARIAN HYPERSTIMULATION E. Karatekeli, H. Özörnek, E. Ergin, B. Ongun EUROFERTIL REPRODUCTIVE.
THE LEEDS CENTRE FOR REPRODUCTIVE MEDICINE SEACROFT HOSPITAL Version 1.1: January 2010.
Ovarian Ageing and Fertility
‘President’s Medal’ for best medical graduate ‘Dr. B.C Roy’s award’ in 1999 for outstanding contribution towards medicine and field of specialty,
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Elonva in poor responders
Approach in infertile couple
Minimal Monitoring of Ovulation Induction (OI) Is It Safe? Mustafa Uğur Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey.
INDIVIDUALIZED IVF TREATMENT
Ovarian reserve and infertility
Homework Questions on p of the GCSE Workbook Due in monday
Emily Bartlett Katrina Bush
SURGICAL TREATMENT OF PCOS SURGICAL TREATMENT OF PCOS Professor T C LI Professor of Reproductive Medicine & Surgery Sheffield.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
In candidates for assisted conception serum FSH but not oestradiol is related to declining ovarian reserve in the fourth decade AP Brown 1, L Maddison.
Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles? Peter Platteau, Johan Smitz, Carola Albano, Per Sørensen Joan-Carles Arce.
IVF update Dr Gregory Jenkins VMO Norwest Private Hospital VMO Sydney West AHS Accredited Specialist Genea.
Moustafa K Eissa MD FRCOG, Hussam Shawkey MD, Ahmad Samir MD, Yasser el-Mazney MBChB Department of Obstetrics & Gynaecology, Minia University and Minia.
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Planning of GnRH antagonist cycles
Hakan Özörnek EUROFERTIL IVF Center Turkey.  No or minimal stimulation  Low cost  Less monitoring  Less side effects (OHSS)  Acceptable pregnancy.
Dr. Milton Leong Director
Antenatal and fertility
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
SL ‘00 Antagonists in patients with previous poor ovarian response Antagonists in patients with previous poor ovarian response Geoffrey H Trew Consultant.
Agonist vs Antagonist Dr. Milton Leong.
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
Natural IVF/ET - treatment success Neda Smiljan Severinski Marko Gospić.
Secondary Sex Traits. Hormones – Proteins made in the brain and sex organs Hormones – Proteins made in the brain and sex organs.
Luteal coasting post GnRH agonist trigger
Methods Interleukim6,Interleukin 1 ,Estradiol and Testosterone Concentrations in Serum and Follicular Fluid of females with stimulated and non-stimulated.
IVF TROUBLESHOOTING ( Clinical Perspective) Malvin Emeraldi M. Luky, Dianing ASR,Muchsin J Family Fertility Center, RSIA Family Fatmawaty Hospital Jakarta,
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Endometriosis 2 Difficulty: Objectives: 1. Management of infertility and endometriosis 2. To choose the most appropriate ART treatment 3. To prevent complications.
Role of decreased androgens in the ovarian response to stimulation in older women Fertil Steril Jan;99(1):5-11 Presented by Hsing-Chun Tsai
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Almond size and shape almond size and shape production and development of oocytes production and development of oocytes production and secretion of oestrogen.
The timeline shows the day of menstrual cycle for a typical patient
How IVF Protocols Work to Enhance the Success of IVF: Agonist vs Antagonist Dr Dimitrios Dovas MD Newlife IVF Greece.
Facilitator: Pawin Puapornpong
Drug protocols for ovulation induction. A
Drug protocols for ovulation induction. A
Ovarian Hyper Stimulation Syndrome (OHSS)
A – The reproductive system
Dealing with ART failure – what should be the stimulation we offer
Changes in the ovarian follicle, endometrial thickness, and serum hormone levels during a 28-day menstrual cycle. P, progesterone; E2, estradiol; LH, luteinizing.
به نام خدا Ovarian hyperstimulation syndrome
Hormonal profile of the same oocyte donors stimulated with either GnRH antagonist or agonist compared with natural cycles.
Supplemental Table 2. Reproductive outcomes
Drug protocols for ovulation induction. A
מערכת הרבייה באדם ערכו וכתבו: אורית עמיאל-שרון והעיקר האהבה
پروتكل آموزش سلامت به مددجو
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Patient-tailored ovarian stimulation for in vitro fertilization
Biomarkers of ovarian response: current and future applications
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.
Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study  Frederic Mitri,
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Dr. Kenneth Egwuda MBBS, PGA-ART(Lon), ESGE(Belg.),FMAS,FWACS,FMCOG
Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting  Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Illustration highlighting the role of insulin in augmenting luteinising hormone (LH)-dependent thecal androgen (A) synthesis, and the reduction in that.
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.
Presentation transcript:

Jisha Rajendran

Keay SD et al. BJOG. 1997

14 70 FSH True reserve – only after stimulation

Individualise the protocol Early initiation of treatment Counsel against stimulation

hormones Dynamic tests ultrasound FSH Most commonly used Easily available D2 or D3 higher values –predictive False positive rate 5% SCREENING TEST! FSH Most commonly used Easily available D2 or D3 higher values –predictive False positive rate 5% SCREENING TEST! AMH Costly test Not widely available Cycle independent Better predictive value Current role - controversial AMH Costly test Not widely available Cycle independent Better predictive value Current role - controversial ultrasound AMH Costly test Not widely available Cycle independent Better predictive value Current role - controversial AFC Simple test Good inter- & intra- observer reproducibility Before starting stimulation Better correlation with retrieval number Current role – widely practised AFC Simple test Good inter- & intra- observer reproducibility Before starting stimulation Better correlation with retrieval number Current role – widely practised

Modify Stimulation Protocol Adjuvant therapy Mini dose protocol “Stop” protocol Short/ Ultra-short/Flare protocol Micro dose flare protocol

Modify Stimulation Protocol

Adjuvant therapy Growth Hormone Androgens Soft Protocols r- LH L-arginine, steroids, aspirin COC pill Estradiol

Growth Hormone Case – Control design 128 – 81 2U s/c Growth Hormone More M-II oocytes, higher E2 levels, pregnancy rates Case – Control design 128 – 81 2U s/c Growth Hormone More M-II oocytes, higher E2 levels, pregnancy rates

Androgens DHES

r- LH

1.Not uncommon 2.Bologna criteria – Age, risk factors, ORT, previous cycle response 3.Hormones + USG – better prediction 4.Modified protocols 5.Adjuvants